Antimetastatic potential of N-acetylcysteine on human prostate cancer cells

Journal of the Medical Association of Thailand

Volumn 95, Issue SUPPL.12, 2012, Pages

  Supabphol, Athikom ^a   Supabphol, Roongtawan ^a  

^a SRINAKHARINWIROT UNIVERSITY   (Thailand)

Author keywords

Cell migration; Cell proliferation; Metastasis; N acetylcysteine (NAC); Postate cancer

Indexed keywords

ACETYLCYSTEINE;

ARTICLE; CANCER INHIBITION; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IC 50; METASTASIS; PROSTATE CANCER;

ACETYLCYSTEINE; ADENOCARCINOMA; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FREE RADICAL SCAVENGERS; HUMANS; MALE; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS;

EID: 84876916324     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Xia SJ, Cui D, Jiang Q. An overview of prostate diseases and their characteristics specific to Asian men. Asian J Androl 2012; 14: 458-64.
2. Vootipruk V. Chapter II-17: Prostate. In: Khuhaprema T, Srivatanakul P, Sriplung H, Wiangnon S, Sumitsawan Y, Attasara P, editors. Cancer in Thailand Vol. IV, 1998-2000 [Internet]. Vol. IV. Bangkok: National Cancer Institute, Thailand; 2010 [cited 2012 Sep 9]: 59-60. Available from: http://www.nci.go.th/cancer_record/cancer_rec1.html
3. Sural YS, Sari D, Turgay AS, Turan D. Dietary agents in prevention of prostate cancer. Asian Pac J Cancer Prev 2008; 9: 183-6.
4. Shiota M, Yokomizo A, Naito S. Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer. Free Radic Biol Med 2011; 51: 1320-8.
5. Arsova-Sarafinovska Z, Eken A, Matevska N, Erdem O, Sayal A, Savaser A, et al. Increased oxidative/nitrosative stress and decreased antioxidant enzyme activities in prostate cancer. Clin Biochem 2009; 42: 1228-35.
6. Blackford MG, Felter T, Gothard MD, Reed MD. Assessment of the clinical use of intravenous and oral N-acetylcysteine in the treatment of acute acetaminophen poisoning in children: a retrospective review. Clin Ther 2011; 33: 1322-30.
7. Johnson MT, McCammon CA, Mullins ME, Halcomb SE. Evaluation of a simplified N-acetylcysteine dosing regimen for the treatment of acetaminophen toxicity. Ann Pharmacother 2011; 45: 713-20.
8. Atkuri KR, Mantovani JJ, Herzenberg LA, Herzenberg LA. N-Acetylcysteine-a safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol 2007; 7: 355-9.
9. Dodd S, Dean O, Copolov DL, Malhi GS, Berk M. N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility. Expert Opin Biol Ther 2008; 8: 1955-62.
10. Kopke RD, Jackson RL, Coleman JK, Liu J, Bielefeld EC, Balough BJ. NAC for noise: from the bench top to the clinic. Hear Res 2007; 226: 114-25.
11. Supabphol A, Muangman V, Chavasiri W, Supabphol R, Gritsanapan W. N-acetylcysteine inhibits proliferation, adhesion, migration and invasion of human bladder cancer cells. J Med Assoc Thai 2009; 92: 1171-7.
12. Chodak GW, Warren KS. Watchful waiting for prostate cancer: a review article. Prostate Cancer Prostatic Dis 2006; 9: 25-9.
13. Nelson WG, De Marzo AM, Isaacs WB. Prostate cancer. N Engl J Med 2003; 349: 366-81.
14. Uygur B, Wu WS. SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis. Mol Cancer 2011; 10: 139.
15. Pulukuri SM, Gondi CS, Lakka SS, Jutla A, Estes N, Gujrati M, et al. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo. J Biol Chem 2005; 280: 36529-40.